But_home
But_blogshome
But_forum
Icon_rss_infobarSubscribe to receive updates
on new articles and posts from this blog.
 
Pixel

ArchivesArchives

Episode #16: PLATO, ticagrelor, and platelet inhibition: Insight from Lars Wallentin audio

Episode #15: Care of advanced heart failure patients with Joe Rogers audio

Episode #14: International collaboration and mentorship with Paul Armstrong audio

Episode #13: RE-LY and PLATO: Direct from ESC Congress 2009 with Ph Gabriel Steg audio

Episode #12: Relationships with industry and conflict of interest with Dr Rob Califf audio

Episode #11: Contemporary approaches to coronary revascularization with Dr Gregg Stone audio

Episode #10: Comparative effectiveness with Dr Harlan Krumholz audio

Episode #9: Dr Melissa Walton-Shirley on delivering primary angioplasty without onsite surgery audio

Episode #8: Antithrombotic drugs for cardiovascular medicine with Dr Magnus Ohman audio

Episode #7: Appropriateness criteria with Dr John Spertus audio

Episode #6: CORE 64 with Dr Julie Miller audio

Episode #5: ATLAS ACS-TIMI 46 trial and antithrombotic therapy with Dr Mike Gibson audio

Episode #4: Testing behavioral intervention, the tyranny of the p-value, and all you need to know about HF-ACTION with Dr Chris O'Connor audio

Episode #3: The JUPITER trial - a home run for science and public health audio

Episode #2: SYNTAX and TRITON-TIMI 38 trials and what they mean for practitioners audio

About The Bob Harrington Show
Take part in this new interactive series! Start by joining Dr Harrington and his guests for a frank and insightful review of the latest clinical trials, events and education in the realm of cardiology. Then it’s your turn: share your thoughts by writing them in the comments box (at left) or by phoning our studios and leaving a voice message: 1-866-996-5440. There’s a show posted every two weeks, why not join in? We value the diverse opinions of our readership — that includes you — and look forward to a hearty exchange!
About Dr Robert A Harrington
Dr Robert A Harrington is a Professor of Medicine at Duke University, Director of the Duke Clinical Research Institute, and a practicing interventional cardiologist. He is the recipient of an NIH Roadmap contract to investigate “best practices” among clinical trial networks, and is a Fellow of the ACC, AHA, SCAI, and American College of Chest Physicians. In addition, he currently serves as a member of the FDA Cardiovascular and Renal Drugs Advisory Committee and is a member of the NHLBI’s study section for clinical trials. A member of the ACC’s Board of Trustees, Dr Harrington chaired the ACC 2006 Annual Scientific Sessions.